Search

Author/Creator Calimeri, T.

2. INTRALESIONAL RITUXIMAB SUPPLEMENTED WITH AUTOLOGOUS SERUM IN RELAPSED CD20+ INDOLENT LYMPHOMAS OF THE CONJUNCTIVA: ACTIVITY AND SAFETY RESULTS OF THE "IRIS" TRIAL. (12th June 2019)

Authors:
Ferreri, A.J.; Sassone, M.; Miserocchi, E.; Govi, S.; Cecchetti, C.; Corti, M.E.; Calimeri, T.; Perrone, S.; Mappa, S.; Ponzoni, M.; Modorati, G.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT). (12th June 2019)

Authors:
Ferreri, A.J.; Sassone, M.C.; Angelillo, P.; Zaja, F.; Re, A.; Spina, M.; Di Rocco, A.; Fabbri, A.; Stelitano, C.; Frezzato, M.; Rusconi, C.; Zambello, R.; Arcari, A.; Bertoldero, G.; De Lorenzo, D.; Volpetti, S.; Calimeri, T.; Perrone, S.; Cecchetti, C.; Ciceri, F.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prophylaxis with high‐dose methotrexate significantly reduces CNS dissemination in patients with diffuse large B‐cell lymphoma (DLBCL) and high‐risk CNS‐IPI score. (June 2017)

Authors:
Ferreri, A.J.; Calimeri, T.; Cecchetti, C.; Vignati, A.; Sassone, M.; Perrone, S.; Girlanda, S.; Ponzoni, M.; Foppoli, M.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
198
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Quantitative muscle mass biomarkers are independent prognosis factors in primary central nervous system lymphoma: The role of L3-skeletal muscle index and temporal muscle thickness. Issue 143 (October 2021)

Authors:
Leone, R.; Sferruzza, G.; Calimeri, T.; Steffanoni, S; Conte, G.M.; De Cobelli, F.; Falini, A.; Ferreri, A.J.M.; Anzalone, N.
Journal:
European journal of radiology
Issue:
Issue 143(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. R‐CHOP PRECEDED BY ENGINEERED TUMOR NECROSIS FACTOR (TNF) IN RELAPSED OR REFRACTORY PRIMARY DIFFUSE LARGE B‐CELL LYMPHOMA OF THE CNS (rPCNSL): FINAL RESULTS OF THE INGRID TRIAL. (12th June 2019)

Authors:
Ferreri, A. J.; Calimeri, T.; Conte, G.; Ponzoni, M.; Fallanca, F.; Cattaneo, D.; Scarano, E.; Flavio, C.; Sassone, M.; Foppoli, M.; Perrone, S.; Cecchetti, C.; Lopedote, P.; Gritti, G.; Castellino, C.; Verga, L.; Olcese, F.; Mazza, R.; Ciceri, F.; Bordignon, C.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. SARS‐COV‐2 INFECTION IN 50 PATIENTS WITH PRIMARY CNS LYMPHOMA: PRESENTATION, EFFECTS ON TUMOR TREATMENT AND OUTCOME IN A SERIES OF THE INTERNATIONAL PCNSL COLLABORATIVE GROUP. (17th June 2021)

Authors:
Ferreri, A. J. M.; Steffanoni, S.; Calimeri, T.; Laurenge, A.; Fox, C. P.; Soussain, C.; Grommes, C.; Sassone, M. C.; Touat, M.; Boot, J.; Crosbie, N.; Chaganti, S.; Dietrich, J.; Alencar, A.; Itchaki, G.; Hoang Xuan, K.; Batchelor, T.; Cwynarski, K.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗